Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Commentary: Thoracic surgery during the COVID-19 pandemic: Recommendations from China
Chi-Fu Jeffrey Yang
The Journal of thoracic and cardiovascular surgery | VOL. 160
Chi-Fu Jeffrey YangChi-Fu Jeffrey Yang
16 Jul 2020
Chronic Kidney Disease in Patients With Renal Cell Carcinoma
Anthony Chang ... Mitchell Rosner
Advances in Chronic Kidney Disease | VOL. 21
Anthony Chang, et. al.Anthony Chang ... Mitchell Rosner
20 Dec 2013
What Really Matters for Cancer Care – Health Systems Strengthening or Technological Innovation?
A Aggarwal ... E Nolte
Clinical Oncology | VOL. 34
A Aggarwal, et. al.A Aggarwal ... E Nolte
04 Mar 2022
View more papers

More From: Lung Cancer

Paper Title
Journal
Date
Author
Evaluating tumour budding could improve the new grading system for lung adenocarcinoma
Kirsi K Volmonen ... Aija H Knuuttila
Lung Cancer | VOL. 199
Kirsi K Volmonen, et. al.Kirsi K Volmonen ... Aija H Knuuttila
01 Jan 2025
Sunvozertinib monotherapy in EGFR tyrosine kinase Inhibitor-Resistant Non-Small cell lung cancer with EGFR mutations
Mengzhao Wang ... James Chih-Hsin Yang
Lung Cancer | VOL. 199
Mengzhao Wang, et. al.Mengzhao Wang ... James Chih-Hsin Yang
01 Jan 2025
Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53
Mingying Wu ... Yuzhou Wang
Lung Cancer | VOL. 199
Mingying Wu, et. al.Mingying Wu ... Yuzhou Wang
01 Jan 2025
Adherence to community-based lung cancer screening in the Yorkshire Lung Screening Trial
Sarah Q Ahmad ... Matthew E.J Callister
Lung Cancer | VOL. -
Sarah Q Ahmad, et. al.Sarah Q Ahmad ... Matthew E.J Callister
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.